Search

Your search keyword '"Campiotti, L"' showing total 93 results

Search Constraints

Start Over You searched for: Author "Campiotti, L" Remove constraint Author: "Campiotti, L"
93 results on '"Campiotti, L"'

Search Results

1. Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)

2. The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry

3. Antibiotic use and associated factors in a large sample of hospitalised older people

4. Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register

5. PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS-MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE

6. Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients

12. MOLECULAR PROLIFE BY NEXT GENERATION SEQUENCING OF ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE: CLINICAL RESULTS FROM THE PROSPECTIVE TRIAL 02/06 OF THE NORTHERN ITALY LEUKEMIA GROUP (NILG)

13. Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia

14. Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients

15. PF227 PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS-MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE

16. Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people

17. NEXT GENERATION SEQUENCING (NGS) CONFIRMED THE ADVERSE CLINICAL IMPACT OF RUNX1 MUTATIONS IN A SUBSET OF ACUTE MYELOID LEUKEMIA NORMAL KARYOTYPE PATIENTS NEGATIVE FOR RISK DEFINING GENES MUTATIONS AND HOMOGENOUSLY TREATED WITHIN A CLINICAL TRIAL (NILG AML 02/06)

18. CLINICAL SIGNIFICANCE OF END OF INDUCTION MINIMAL RESIDUAL DISEASE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION AFTER A SINGLE CHEMOTHERAPY COURSE

19. Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study

21. Recurrent ETNK1 mutations in atypical chronic myeloid leukemia

22. TWO-STEP RESPONSE-ORIENTED INDUCTION PREDICTS LONG-TERM OUTCOME OF ADULT PATIENTS WITH STANDARD- AND HIGH-RISK ACUTE MYELOID LEUKAEMIA (AML): A NORTHERN ITALY LEUKAEMIA GROUP (NILG) STUDY

23. IN ADULT ACUTE MYELOID LEUKAEMIA (AML) ALL RISK SUBSETS BENEFIT FROM A SEQUENTIAL HIGH-DOSE PROGRAMME AS EARLY RESCUE OF FIRST INDUCTION FAILURE: A REPORT FROM NORTHERN ITALY LEUKAEMIA GROUP (NILG)

29. A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study)

31. Limited Feasibility of Double Transplant Program: A Multicenter Study on 151 Multiple Myeloma Patients Aged≤65 Years.

32. Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry

33. What changed in the Italian internal medicine and geriatric wards during the lockdown

34. High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)

35. Pain and Frailty in Hospitalized Older Adults

36. Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry

37. Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients

38. Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06

39. SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub

40. Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients

41. Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia

42. Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis

43. Recurrent ETNK1 mutations in atypical chronic myeloid leukemia

44. Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia

45. A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study)

46. Limited feasibility of double transplant program: A multicenter study on 151 multiple myeloma patients aged <= 65 years

48. High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy.

49. Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta-analysis.

50. Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer.

Catalog

Books, media, physical & digital resources